These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6424727)

  • 1. Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.
    Thuillier L; Perignon JL; Houllier AM; Munier A; Cartier P
    Biochim Biophys Acta; 1984 Apr; 798(3):343-9. PubMed ID: 6424727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage of 5'-deoxy-methylthioadenosine into purines and methionine by lymphoid cells and inhibition of cell proliferation.
    Christa L; Thuillier L; Munier A; Perignon JL
    Biochim Biophys Acta; 1984 Feb; 803(1-2):7-10. PubMed ID: 6421333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of de novo purine synthesis in lymphocyte transformation.
    Allison AC; Hovi T; Watts RW; Webster AD
    Ciba Found Symp; 1977; (48):207-24. PubMed ID: 415850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulation.
    Peters GJ; Oosterhof A; Veerkamp JH
    Biochim Biophys Acta; 1983 Jan; 755(1):127-36. PubMed ID: 6402034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
    Gordon RB; Blackwell K; Emmerson BT
    Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.
    Boss GR
    Biochem J; 1987 Mar; 242(2):425-31. PubMed ID: 3109390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of purine nucleoside phosphorylase substrates on the mitogen-induced stimulation of murine T and B spleen cells.
    Martineau R; Willemot J
    Immunopharmacology; 1983 Dec; 6(4):289-302. PubMed ID: 6418686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
    Russell NH; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
    Sidi Y; Hudson JL; Mitchell BS
    Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.
    Allison AC; Hovi T; Watts RW; Webster AD
    Lancet; 1975 Dec; 2(7946):1179-83. PubMed ID: 53661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotope-dilution analysis of the effects of deoxyguanosine and deoxyadenosine on the incorporation of thymidine and deoxycytidine by hydroxyurea-treated thymus cells.
    Scott FW; Forsdyke DR
    Biochem J; 1980 Sep; 190(3):721-30. PubMed ID: 6970575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-5'-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells.
    Thompson LF
    J Immunol; 1985 Jun; 134(6):3794-7. PubMed ID: 2985697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of deoxyadenosine and deoxyguanosine toxicity at different stages of lymphocyte activation.
    Scharenberg JG; Rijkers GT; Toebes EA; Staal GE; Zegers BJ
    Scand J Immunol; 1988 Jul; 28(1):87-93. PubMed ID: 3135585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.